The visual impact is dramatic because people see your face and neck in every interaction
Out of all patients with an overweight or obesity diagnosis who were prescribed a GLP-1 drug, the percentage of patients who had behavioral health services related to their condition declined from 2019 to 2024
N Engl J Med 373(1):1122 Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I et al (2021) Once-weekly semaglutide in adults with overweight or obesity
PlexusDx compounded semaglutide from licensed 503A pharmacies is dosed according to the established weekly protocol, ensuring you receive medication prepared for safe, predictable delivery
The CDC estimates that nearly 42% of the U.S
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. The Lancet